Singapore, July 17, 2008: Living Cell Technologies is hosting a seminar on diabetes in Auckland in New Zealand to discuss current developments with porcine islet transplant technologies.
LCT, which is based in both Australia and New Zealand said its medical director Prof. Bob Elliott will speak to ‘world leading medical scientists and specialists’ on August 8.
A prepared company release said the one-day meeting brings together experts with many years' experience who are developing methods for delivering insulin-producing cells to patients with insulin dependant Type 1 diabetes. The topics they will address include the health status of the pigs whose insulin producing cells are implanted into humans, the absence of immunosuppression drugs; early clinical data from human studies and post transplant monitoring.
The release also said experts such as Professor David White, Robarts Institute Canada, Professor Gregory Korbutt, University of Alberta, Canada, Professor Nikolai Skaletsky, the Sklifosovsky Institute, Moscow, Professor Riccaardo Calafiore, University of Perugia, Italy and Dr Linda Scobie, University of Glasgow, will be presenting at the seminar, among others.
Professor Elliott said: “We are delighted to have so many islet implant experts participating in this meeting which will be very focused on the issues surrounding human trials. The early results that have been obtained to date from LCT’s porcine islet implants have been extremely encouraging. I look forward to discussing the results with fellow scientists and practitioners who see the importance of islet cell treatment and are keen to advance this technology rapidly for the benefit of people with insulin dependent Type 1 diabetes.”
| 
Comment on this article
